Table 3

Comparison of cases and controls in terms of exposure to vaccination

Exposure and time window before the index dateCases (n = 198)Controls (n = 878)Crude ORs (95% CI)Adjusted ORs (95% CI)
Any vaccine, n (%) 
    12 mo 66 (33.3) 303 (34.5) 1.0 (0.7-1.4) 1.0 (0.7, 1.4) 
    Without dates of vaccination 5 (2.5) 24 (2.7) 1.0 (0.4-2.7) 1.0 (0.4, 2.8) 
    No exposure 127 (64.1) 551 (62.8) 
    6 mo 42 (21.2) 177 (20.2) 1.1 (0.7-1.7) 1.1 (0.7, 1.7) 
    Without dates of vaccination 6 (3.0) 24 (2.7) 1.2 (0.5-3.2) 1.3 (0.5, 3.2) 
    No exposure 150 (75.8) 677 (77.1) 
    2 mo 17 (8.6) 62 (7.1) 1.3 (0.7-2.4) 1.3 (0.7, 2.3) 
    Without dates of vaccination* 6 (3.0) 24 (2.7)   
    No exposure 175 (88.4) 792 (90.2) 
Influenza vaccine, n (%) 
    12 mo 43 (21.7) 242 (27.6) 0.7 (0.5-1.1) 0.7 (0.5-1.1) 
    Without dates of vaccination 1 (0.5) 9 (1.0) 0.5 (0.1-4.1) 0.5 (0.1-4.4) 
    No exposure 154 (77.8) 627 (71.4) 
    6 mo 28 (14.1) 133 (15.1) 0.9 (0.6-1.6) 0.9 (0.6-1.6) 
    Without dates of vaccination 2 (1.0) 9 (1.0) 1.1 (0.2-5.2) 1.2 (0.3-6.0) 
    No exposure 168 (84.8) 736 (83.8) 
    2 mo 9 (4.5) 43 (4.9) 1.0 (0.4-2.1) 0.9 (0.4-2.1) 
    Without dates of vaccination* 2 (1.0) 9 (1.0)   
    No exposure 187 (94.4) 826 (94.1) 
DTPP vaccine, n (%) 
    12 mo 18 (9.1) 62 (7.1) 1.3 (0.8-2.3) 1.4 (0.8-2.4)§ 
    Without dates of vaccination 3 (1.5) 13 (1.5) 1.2 (0.3-4.1) 1.1 (0.3-4.1)§ 
    No exposure 177 (89.4) 803 (91.5) 
    6 mo 10 (5.1) 34 (3.9) 1.3 (0.6-2.7) 1.3 (0.6-2.7)§ 
    Without dates of vaccination 3 (1.5) 13 (1.5) 1.2 (0.3-4.1) 1.1 (0.3-4.0)§ 
    No exposure 185 (93.4) 831 (94.6) 
    2 mo 4 (2.0)* 13 (1.5)* 1.5 (0.5-4.6) 1.5 (0.5-4.5) 
    Without dates of vaccination* 3 (1.5) 13 (1.5)   
    No exposure 191 (96.5) 852 (97.0)   
Exposure and time window before the index dateCases (n = 198)Controls (n = 878)Crude ORs (95% CI)Adjusted ORs (95% CI)
Any vaccine, n (%) 
    12 mo 66 (33.3) 303 (34.5) 1.0 (0.7-1.4) 1.0 (0.7, 1.4) 
    Without dates of vaccination 5 (2.5) 24 (2.7) 1.0 (0.4-2.7) 1.0 (0.4, 2.8) 
    No exposure 127 (64.1) 551 (62.8) 
    6 mo 42 (21.2) 177 (20.2) 1.1 (0.7-1.7) 1.1 (0.7, 1.7) 
    Without dates of vaccination 6 (3.0) 24 (2.7) 1.2 (0.5-3.2) 1.3 (0.5, 3.2) 
    No exposure 150 (75.8) 677 (77.1) 
    2 mo 17 (8.6) 62 (7.1) 1.3 (0.7-2.4) 1.3 (0.7, 2.3) 
    Without dates of vaccination* 6 (3.0) 24 (2.7)   
    No exposure 175 (88.4) 792 (90.2) 
Influenza vaccine, n (%) 
    12 mo 43 (21.7) 242 (27.6) 0.7 (0.5-1.1) 0.7 (0.5-1.1) 
    Without dates of vaccination 1 (0.5) 9 (1.0) 0.5 (0.1-4.1) 0.5 (0.1-4.4) 
    No exposure 154 (77.8) 627 (71.4) 
    6 mo 28 (14.1) 133 (15.1) 0.9 (0.6-1.6) 0.9 (0.6-1.6) 
    Without dates of vaccination 2 (1.0) 9 (1.0) 1.1 (0.2-5.2) 1.2 (0.3-6.0) 
    No exposure 168 (84.8) 736 (83.8) 
    2 mo 9 (4.5) 43 (4.9) 1.0 (0.4-2.1) 0.9 (0.4-2.1) 
    Without dates of vaccination* 2 (1.0) 9 (1.0)   
    No exposure 187 (94.4) 826 (94.1) 
DTPP vaccine, n (%) 
    12 mo 18 (9.1) 62 (7.1) 1.3 (0.8-2.3) 1.4 (0.8-2.4)§ 
    Without dates of vaccination 3 (1.5) 13 (1.5) 1.2 (0.3-4.1) 1.1 (0.3-4.1)§ 
    No exposure 177 (89.4) 803 (91.5) 
    6 mo 10 (5.1) 34 (3.9) 1.3 (0.6-2.7) 1.3 (0.6-2.7)§ 
    Without dates of vaccination 3 (1.5) 13 (1.5) 1.2 (0.3-4.1) 1.1 (0.3-4.0)§ 
    No exposure 185 (93.4) 831 (94.6) 
    2 mo 4 (2.0)* 13 (1.5)* 1.5 (0.5-4.6) 1.5 (0.5-4.5) 
    Without dates of vaccination* 3 (1.5) 13 (1.5)   
    No exposure 191 (96.5) 852 (97.0)   
*

The numbers exposed were too small to calculate meaningful ORs.

ORs were adjusted for: family history of autoimmune disorders (yes/no/unknown/missing) and systemic NSAID(s) in the 12 mo before the index date (yes/no).

ORs were also adjusted for vaccination with any vaccine other than influenza in the 24 mo before the index date (yes/no).

§

ORs were also adjusted for vaccination with any vaccine other than DTPP in the 24 mo before the index date (yes/no).

or Create an Account

Close Modal
Close Modal